TITLE

A new dawn for antiretrovirals

AUTHOR(S)
Sutherland, Rebecca Kay
PUB. DATE
February 2005
SOURCE
BMJ: British Medical Journal (International Edition);2/12/2005, Vol. 330 Issue 7487, p371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Documents the introduction of antiretroviral drugs to HIV patients in Africa in 2004. Challenges faced by the author in obtaining antiretrovirals for the community he served in South Africa; Clinical progress of those receiving the drugs; Positive effects of antiretroviral treatment, including its role in keeping families together for longer, and reducing the transmission of HIV.
ACCESSION #
16132346

 

Related Articles

  • Delayed Progression to Death and to AIDS in a Hong Kong Cohort of Patients with Advanced HIV Type 1 Disease During the Era of Highly Active Antiretroviral Therapy. Ka Hing Wong; Kenny Chi Wai Chan; Shui Shan Lee // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p853 

    Background. The magnitude of the impact of highly active antiretroviral therapy (HAART) since its introduction in non-Western countries is not entirely clear. We studied disease progression among adult patients with advanced human immunodeficiency virus type 1 (HIV-1) infection in the pre-HAART...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

  • Modelling T4 cell count as a marker of HIV progression in the absence of any defense mechanism. Yadavalli, Venkata S. Sarma; Labeodan, Moremi Morire OreOluwapo; Udayabaskaran, Swaminathan; Forche, N. // Orion;2010, Vol. 26 Issue 2, p113 

    The T4 cell count, which is considered one of the markers of disease progression in an HIV infected individual, is modelled in this paper. The World Health Organisation has recently advocated that countries encourage HIV infected individuals to commence antiretroviral treatments once their T4...

  • HIV-Induced T-Cell Activation/Exhaustion in Rectal Mucosa Is Controlled Only Partially by Antiretroviral Treatment. Rueda, Cesar Mauricio; Velilla, Paula Andrea; Chougnet, Claire A.; Montoya, Carlos Julio; Rugeles, Maria Teresa // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Peripheral blood T-cells from untreated HIV-1-infected patients exhibit reduced immune responses, usually associated with a hyperactivated/exhausted phenotype compared to HAART treated patients. However, it is not clear whether HAART ameliorates this altered phenotype of T-cells in the...

  • Antiretroviral prescribing delayed among certain patients.  // PharmacoEconomics & Outcomes News;4/24/2004, Issue 451, p7 

    Discusses a study conducted by researchers in the U.S. in April 2004, which revealed the delay of antiretroviral therapy for nonadherent HIV-infected patients caused by physicians who follow guidelines on antiretroviral treatment. Number of patients with HIV infections that were evaluated;...

  • Prevalence of intestinal parasites in relation to CD4 counts and anaemia among HIV-infected patients in Benin City, Edo State, Nigeria. Akinbo, Frederick O.; Okaka, Christopher E.; Omoregie, Richard // Tanzania Journal of Health Research;Feb2011, Vol. 13 Issue 1, p10 

    Parasitic infections continue to take their toll on HIV positive patients by influencing the blood qualitatively and quantitatively. The objective of this study was to determine the prevalence of intestinal parasitic infections in relation to anaemia and CD4 counts among HIV-infected patients in...

  • Partner protection. Coghlan, Andy // New Scientist;4/28/2012, Vol. 214 Issue 2862, p4 

    The article discusses a recommendation from the World Health Organization (WHO) to immediately give any person with HIV, whose partner is not infected, antiretroviral drugs to prevent HIV transmission.

  • Switch rates to second-line HIV treatment relatively low.  // PharmacoEconomics & Outcomes News;8/9/2008, Issue 559, p11 

    The article discusses research being done on HIV antiretroviral therapy (ART). It references a study by M. Pujades-Rodriguez et al, published in the July 11, 2008 issue of "AIDS." Using data from patients in Africa, Asia, Latin America and Eastern Europe, the study showed that the rate of switch...

  • The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study. Munthali, Lumbani; Khan, Palwasha Y.; Mwaungulu, Nimrod J.; Chilongo, Femia; Floyd, Sian; Kayange, Michael; Glynn, Judith R.; French, Neil; Crampin, Amelia C. // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background HIV infection reduces the likelihood that individuals with pulmonary tuberculosis are smear positive and that they have cavitatory disease. Antiretroviral therapy (ART) may shift the pattern of disease to be more similar to that of HIV negative patients. This would aid diagnosis-...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics